Enzymotec Ltd

ENZY

Delisted

ENZY was delisted on the 10th of January, 2018.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	PC 1 Paulson & Co New York	$35.4M	–	–	–
2	VAM 2 Visium Asset Management New York	$18.4M	+$367K	+40,000	+2%
3	3 Goldman Sachs New York	$6.06M	+$5.85M	+637,281	+721%
4	4 Millennium Management New York	$1.58M	-$193K	-20,981	-10%
5	5 California Public Employees Retirement System Sacramento, California	$1.29M	–	–	–
6	6 Fidelity Investments Boston, Massachusetts	$1.08M	-$7.19M	-783,093	-86%
7	7 T. Rowe Price Associates Baltimore, Maryland	$985K	-$628K	-68,445	-18%
8	8 Bank of America Charlotte, North Carolina	$838K	+$918K	+100,000	+25,000%
9	SPPAM 9 Summit Partners Public Asset Management Boston, Massachusetts	$760K	+$835K	+90,960	New
10	10 Renaissance Technologies New York	$689K	+$260K	+28,294	+52%
11	MHP 11 Manatuck Hill Partners Westport, Connecticut	$187K	+$206K	+22,400	New
12	12 Deutsche Bank Frankfurt Am Main Ge, Germany	$172K	+$10.1K	+1,105	+6%
13	BIT 13 BlackRock Institutional Trust San Francisco, California	$137K	–	–	–
14	14 Morgan Stanley New York	$73K	+$48.5K	+5,283	+153%
15	15 Acadian Asset Management Boston, Massachusetts	$57K	–	–	–
16	16 UBS Group Zurich, Switzerland	$36K	-$4.54K	-495	-10%
17	AIG 17 American International Group New York	$6.68K	–	–	–
18	18 Royal Bank of Canada Toronto, Ontario, Canada	$1K	-$37	-4	-3%
19	19 Allianz Asset Management Munich, Germany	–	-$112K	-15,598	Closed
20	20 Stifel Financial St. Louis, Missouri	–	-$78K	-10,768	Closed
21	21 Wells Fargo San Francisco, California	–	-$1K	-100	Closed